Product Description: Droxicam (Ombolan) is a non-steroidal anti-inflammatory agent, with strong analgesic activity. Droxicam acts by inhibiting PGE2 varies, and is characterised by being a pro-drug of Piroxicam (HY-B0253). Droxicam is well tolerated with slight side effects in the said mucosa. Droxicam does not show cardiovascular or respiratory effects in cats, and inhibits peritoneal capillary permeability in mouse[1][2].
Applications: COVID-19-immunoregulation
Formula: C16H11N3O5S
References: [1]Farré AJ, et al. Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent. Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):407-22. /[2]Jané F, et al. Droxicam: a pharmacological and clinical review of a new NSAID. Eur J Rheumatol Inflamm. 1991;11(4):3-9.
CAS Number: 90101-16-9
Molecular Weight: 357.34
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Prostaglandin Receptor
Deutsch
English
